NanoViricides
NNVC
38 hedge funds and large institutions have $2.67M invested in NanoViricides in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 7 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
0.02% more ownership
Funds ownership: 0.24% → 0.26% (+0.02%)
6% less capital invested
Capital invested by funds: $2.85M → $2.67M (-$181K)
14% less funds holding
Funds holding: 44 → 38 (-6)
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$37.8K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.3K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$10.3K |
| 4 |
SCA
STALEY CAPITAL ADVISERS
Pittsburgh,
Pennsylvania
|
+$10.2K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$6.45K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$53K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13K |
| 3 |
QSS
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
|
-$9K |
| 4 |
Morgan Stanley
New York
|
-$5.55K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$4.49K |
NNVC Hedge Fund Activity: Q1 2018 in Review
38 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2018, worth a combined $2.67M — down 6.3% from $2.85M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of NNVC and 1 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 9 added.
The largest buyer was Renaissance Technologies, adding an estimated $37.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $53K sold.
- 38 institutional investors held NanoViricides (NNVC) as of Q1 2018, down from 44 in Q4 2017.
- Funds reported $2.67M of NanoViricides stock for Q1 2018, down 6.3% quarter-over-quarter.
- 1 fund opened new NanoViricides positions in Q1 2018 and 7 closed out, a net change of -6 holders.
- The largest NanoViricides buyer in Q1 2018 was Renaissance Technologies, an estimated $37.8K added.
- The largest NanoViricides seller in Q1 2018 was Citadel Advisors, an estimated $53K sold.
Based on aggregated 13F filings for Q1 2018.